WebJul 31, 2024 · Background Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a paucity of information as to patterns of use and the results achieved in actual clinical practice. Materials and methods The study population comprised patients with AGC in the AGAMENON registry who had received second … WebRecently, Ettrich et al conducted a phase II trial examining the activity of the docetaxel and oxaliplatin (DocOx) combination as a second-line treatment for advanced pancreatic cancer. 32 Tumor response was achieved in 15.9% of the patients, with a disease control rate of 48% after the first two treatment cycles.
The Impact of Systemic Therapy Beyond First-line Treatment for
WebAug 31, 2024 · There were 68.5% of patients for whom we observed a first line of treatment (including systemic therapy and radiotherapy), 43.9% had a second line, 30.5% had a third line, and 20.5% had four or more lines (Supplemental Table 4 ). WebApr 29, 2024 · 1L First-line 2L Second-line 2L+ Second-line or subsequent line 3L Third-line 3L+ Third-line or subsequent line 5-FU 5-fluorouracil AE Adverse event BLA Biologics License... diament inowroclaw
No Clear Choice for Second-Line Therapy in Advanced Cervical Cancer
WebMar 30, 2024 · First-line treatment is the one that, for most people, is expected to provide the best results with the fewest number of side effects. In contrast, second-line … WebApr 10, 2024 · Gastric cancer (GC) is the fifth most common cancer worldwide, and the geographic distribution of GC incidence and mortality is disproportionate, with the highest rates observed in east Asian countries, such as South Korea, Mongolia, and Japan [1, 2].In Japan, the current standard of care for unresectable advanced, recurrent, or metastatic … WebAug 26, 2024 · This is the first study comparing treatment choices beyond first-line and corresponding survival outcomes across race/ethnicity groups among patients in the … diamentions of canister filter